- •Multiple Sclerosis is associated with thinning of the inner retina.
- •Female gender and MRI activity was associated with thinning of the MRNFL.
- •Most of the neuroaxonal thinning occurs early in the disease, with another phase of neurodegeneration - Most possibly in later stages.
- •Optical coherence tomography can be a potential outcome measure in therapeutic multiple sclerosis trials.
Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:Subscribe to Multiple Sclerosis and Related Disorders
- Disease course heterogeneity and OCT in multiple sclerosis.Mult. Scler. 2014; 20: 1198-1206
- Bidirectional trans-synaptic axonal degeneration in the visual pathway in multiple sclerosis.J. Neurol. Neurosurg. Psychiatry. 2015; 86: 419-424
- Timing of retinal neuronal and axonal loss in MS: a longitudinal OCT study.J. Neurol. 2016;
- Timing of retinal neuronal and axonal loss in MS: a longitudinal OCT study.J. Neurol. 2016; 263: 1323-1331
- Ganglion cell analysis in acute optic neuritis.Mult. Scler. Relat. Disord. 2016; 5: 66-69
- Disease-modifying therapies modulate retinal atrophy in multiple sclerosis: a retrospective study.Neurology. 2017; 88: 525-532
- Trans-synaptic axonal degeneration in the visual pathway in multiple sclerosis.Ann. Neurol. 2014; 75: 98-107
- Microcystic macular oedema in multiple sclerosis is associated with disease severity.Brain. 2012; 135: 1786-1793
- Optical coherence tomography indicates disease activity prior to clinical onset of central nervous system demyelination.Mult. Scler. 2016; 22: 893-900
- Association of retinal architecture, intrathecal immunity, and clinical course in multiple sclerosis.JAMA Neurol. 2017; 74: 847-856
- Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS).Neurology. 1983; 33: 1444-1452
- Effect of relapses on development of residual deficit in multiple sclerosis.Neurology. 2003; 61: 1528-1532
- Tracking changes over time in retinal nerve fiber layer and ganglion cell-inner plexiform layer thickness in multiple sclerosis.Mult. Scler. 2014; 20: 1331-1341
- Fingolimod treatment in multiple sclerosis leads to increased macular volume.Neurology. 2013; 80: 139-144
- Retinal damage in multiple sclerosis disease subtypes measured by high-resolution optical coherence tomography.Mult. Scler. Int. 2012; 2012: 530305
- Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria.Ann. Neurol. 2011; 69: 292-302
- Active MS is associated with accelerated retinal ganglion cell/inner plexiform layer thinning.Neurology. 2013; 80: 47-54
- Microcystic macular oedema, thickness of the inner nuclear layer of the retina, and disease characteristics in multiple sclerosis: a retrospective study.Lancet Neurol. 2012; 11: 963-972
- Relationships between retinal axonal and neuronal measures and global central nervous system pathology in multiple sclerosis.JAMA Neurol. 2013; 70: 34-43
- Optical coherence tomography reflects brain atrophy in multiple sclerosis: a four-year study.Ann. Neurol. 2015; 78: 801-813
- MRI lesions as a surrogate for relapses in multiple sclerosis: a meta-analysis of randomised trials.Lancet Neurol. 2013; 12: 669-676
- The OSCAR-IB consensus criteria for retinal OCT quality assessment.PLoS One. 2012; 7: e34823
- New perspectives in the natural history of multiple sclerosis.Neurology. 2010; 74: 2004-2015